Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Smoking Cessation Market Research

Nicotine Replacement Therapy Market

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 180 Pages Transparency Market Research Pvt. Ltd. July, 2023 TNPR18164161
Best Price Guarantee
Price from $5,795
Length 180 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date July, 2023
SKU TNPR18164161

Nicotine Replacement Therapy Market (Product Type: Smoking Cessation Aids and Vaping System; Distribution Channel: Retail Pharmacies, Hospital Pharmacies, and Online Stores) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031


Nicotine Replacement Therapy Market – Scope of Report

TMR’s report on the global nicotine replacement therapy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global nicotine replacement therapy market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global nicotine replacement therapy market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the nicotine replacement therapy market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global nicotine replacement therapy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global nicotine replacement therapy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global nicotine replacement therapy market.

The report delves into the competitive landscape of the global nicotine replacement therapy market. Key players operating in the global nicotine replacement therapy market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global nicotine replacement therapy market profiled in this report.

Key Questions Answered in Global Nicotine Replacement Therapy Market Report
  • What is the sales/revenue generated by nicotine replacement therapy across all regions during the forecast period?
  • What are the opportunities in the global nicotine replacement therapy market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Nicotine Replacement Therapy Market – Research Objectives and Research Approach

The comprehensive report on the global nicotine replacement therapy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global nicotine replacement therapy market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global nicotine replacement therapy market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nicotine Replacement Therapy Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Nicotine Replacement Therapy Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Regulatory landscape analysis by key countries
5.2. Supply/Value chain analysis
5.3. Recent Developments/Latest product launches/Key strategies
5.4. Prevalence/Incidence of Smoking Addiction by key regions
5.5. Prevalence/Incidence of Individuals Undergoing NRT Therapy by Region
5.6. COVID-19 Pandemic Impact on Industry
6. Global Nicotine Replacement Therapy Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017-2031
6.3.1. Smoking Cessation Aids
6.3.1.1. Nicotine Inhalers
6.3.1.2. Nicotine Gums
6.3.1.3. Nicotine Lozenges
6.3.1.4. Nicotine Patches
6.3.1.5. Others
6.3.2. Vaping System
6.3.2.1. E-cigarettes
6.3.2.2. Heat-not-burn Tobacco Products
6.4. Market Attractiveness Analysis, by Product Type
7. Global Nicotine Replacement Therapy Market Analysis and Forecast, by Distribution Channel
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Distribution Channel, 2017-2031
7.3.1. Retail Pharmacies
7.3.2. Hospital Pharmacies
7.3.3. Online Stores
7.4. Market Attractiveness Analysis, by Distribution Channel
8. Global Nicotine Replacement Therapy Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Nicotine Replacement Therapy Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product Type, 2017-2031
9.2.1. Smoking Cessation Aids
9.2.1.1. Nicotine Inhalers
9.2.1.2. Nicotine Gums
9.2.1.3. Nicotine Lozenges
9.2.1.4. Nicotine Patches
9.2.1.5. Others
9.2.2. Vaping System
9.2.2.1. E-cigarettes
9.2.2.2. Heat-not-burn Tobacco Products
9.3. Market Value Forecast, by Distribution Channel, 2017-2031
9.3.1. Retail Pharmacies
9.3.2. Hospital Pharmacies
9.3.3. Online Stores
9.4. Market Value Forecast, by Country, 2017-2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By Distribution Channel
9.5.3. By Country
10. Europe Nicotine Replacement Therapy Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017-2031
10.2.1. Smoking Cessation Aids
10.2.1.1. Nicotine Inhalers
10.2.1.2. Nicotine Gums
10.2.1.3. Nicotine Lozenges
10.2.1.4. Nicotine Patches
10.2.1.5. Others
10.2.2. Vaping System
10.2.2.1. E-cigarettes
10.2.2.2. Heat-not-burn Tobacco Products
10.3. Market Value Forecast, by Distribution Channel, 2017-2031
10.3.1. Retail Pharmacies
10.3.2. Hospital Pharmacies
10.3.3. Online Stores
10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By Distribution Channel
10.5.3. By Country/Sub-region
11. Asia Pacific Nicotine Replacement Therapy Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017-2031
11.2.1. Smoking Cessation Aids
11.2.1.1. Nicotine Inhalers
11.2.1.2. Nicotine Gums
11.2.1.3. Nicotine Lozenges
11.2.1.4. Nicotine Patches
11.2.1.5. Others
11.2.2. Vaping System
11.2.2.1. E-cigarettes
11.2.2.2. Heat-not-burn Tobacco Products
11.3. Market Value Forecast, by Distribution Channel, 2017-2031
11.3.1. Retail Pharmacies
11.3.2. Hospital Pharmacies
11.3.3. Online Stores
11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By Distribution Channel
11.5.3. By Country/Sub-region
12. Latin America Nicotine Replacement Therapy Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017-2031
12.2.1. Smoking Cessation Aids
12.2.1.1. Nicotine Inhalers
12.2.1.2. Nicotine Gums
12.2.1.3. Nicotine Lozenges
12.2.1.4. Nicotine Patches
12.2.1.5. Others
12.2.2. Vaping System
12.2.2.1. E-cigarettes
12.2.2.2. Heat-not-burn Tobacco Products
12.3. Market Value Forecast, by Distribution Channel, 2017-2031
12.3.1. Retail Pharmacies
12.3.2. Hospital Pharmacies
12.3.3. Online Stores
12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By Distribution Channel
12.5.3. By Country/Sub-region
13. Middle East & Africa Nicotine Replacement Therapy Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017-2031
13.2.1. Smoking Cessation Aids
13.2.1.1. Nicotine Inhalers
13.2.1.2. Nicotine Gums
13.2.1.3. Nicotine Lozenges
13.2.1.4. Nicotine Patches
13.2.1.5. Others
13.2.2. Vaping System
13.2.2.1. E-cigarettes
13.2.2.2. Heat-not-burn Tobacco Products
13.3. Market Value Forecast, by Distribution Channel, 2017-2031
13.3.1. Retail Pharmacies
13.3.2. Hospital Pharmacies
13.3.3. Online Stores
13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By Distribution Channel
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2022
14.3. Company Profiles
14.3.1. Haleon Group of Companies
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Pfizer, Inc.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. McNeil AB (Johnson & Johnson)
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. SAABI NZ PTY Limited
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. PL Developments
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Cipla Limited
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. BAT plc
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. JT International SA
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Imperial Brands plc
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. Sparsha Pharma International Pvt. Ltd.
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. Financial Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
14.3.11. Pierre Fabre S.A.
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Product Portfolio
14.3.11.3. Financial Overview
14.3.11.4. SWOT Analysis
14.3.11.5. Strategic Overview
14.3.12. Lucy Goods
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Product Portfolio
14.3.12.2. Financial Overview
14.3.12.3. SWOT Analysis
14.3.12.4. Strategic Overview
14.3.13. Rubicon Research Pvt. Ltd.
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Product Portfolio
14.3.13.3. Financial Overview
14.3.13.4. SWOT Analysis
14.3.13.5. Strategic Overview
14.3.14. JUUL Labs, Inc.
14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.14.2. Product Portfolio
14.3.14.3. Financial Overview
14.3.14.4. SWOT Analysis
14.3.14.5. Strategic Overview
14.3.15. Fontem Holdings 4 B.V.
14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.15.2. Product Portfolio
14.3.15.3. Financial Overview
14.3.15.4. SWOT Analysis
14.3.15.5. Strategic Overview
14.3.16. Philip Morris International, Inc.
14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.16.2. Product Portfolio
14.3.16.3. Financial Overview
14.3.16.4. SWOT Analysis
14.3.16.5. Strategic Overview
14.3.17. Perrigo Company plc
14.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.17.2. Product Portfolio
14.3.17.3. Financial Overview
14.3.17.4. SWOT Analysis
14.3.17.5. Strategic Overview

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings